Show items per page
Elements: 5
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis Alpizar Rodriguez, Deshire; Brulhart, Laure Sophie; Mueller, Ruediger B; Möller, Burkhard; ... Finckh, Axel 2017
add to browser selection
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) Iannone, Florenzo; Courvoisier, Delphine S; Gottenberg, Jacques Eric; Hernandez, Maria Victoria; ... Finckh, Axel 2017
add to browser selection
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis Gottenberg, J E; Courvoisier, D S; Hernandez, M V; Iannone, F; ... Finckh, Axel 2016
add to browser selection
HLA-DRB1 and HLA-DQB1 allele associations in an Albanian patient population with rheumatoid arthritis: correlations with the specific autoantibody markers and inter-population DRB1 allele frequency variability Prifti-Kurti, Margarita; Nunes, Jose Manuel; Shyti, Erkena; Ylli, Zamira; ... Sulcebe, Genc 2014
add to browser selection
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2011